1. $7.4 billion – In Re National Prescription Opiate Litigation, Case No. 17-MD02804 (N.D. Ohio Feb. 25, 2022) (settlement agreement reached with distributorMcKesson to resolve the vast majority of the opioid lawsuits filed by state andlocal governmental entities).2. $6.1 billion – In Re National Prescription Opiate Litigation, Case No. 17-MD02804 (N.D. Ohio Feb. 25, 2022) (settlement agreement reached with distributorAmerisourceBergen to resolve the vast majority of the opioid lawsuits filed bystate and local governmental entities).3. $6 billion – In Re National Prescription Opiate Litigation, Case No. 17-MD02804 (N.D. Ohio Feb. 25, 2022) (settlement agreement reached with distributorCardinal Health to resolve the vast majority of the opioid lawsuits filed by stateand local governmental entities).4. $5.5 billion – In Re National Prescription Opiate Litigation, Case No. 17-MD02804 (N.D. Ohio Mar. 3, 2022) (settlement agreement reached with 13 statesby OxyContin manufacturer Purdue Pharma to resolve claims that the companyheld to fuel the U.S. opioid epidemic).290© Duane Morris LLP 2023Duane Morris Class Action Review – 2023
It seems that your browser's pop-up blocker has prevented us from opening a new window/tab. Please click the button below to open the link manually.
Table of contents
11
42
55
67
86
98
114
129
144
173
189
209
219
238
244
258
282
293
303
314
330
354
371
381
386
391
422
